| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000028840 |
| Receipt No. | R000033008 |
| Scientific Title | Efficacy of Endoscopy with linked color imaging (LCI) for superficial nonampullary duodenal epithelial tumor (SNADET) |
| Date of disclosure of the study information | 2017/08/25 |
| Last modified on | 2022/01/10 (Ver. 9) |
| Basic information | ||
| Public title | Efficacy of Endoscopy with linked color imaging (LCI) for superficial nonampullary duodenal epithelial tumor (SNADET) | |
| Acronym | LCI for SNADET | |
| Scientific Title | Efficacy of Endoscopy with linked color imaging (LCI) for superficial nonampullary duodenal epithelial tumor (SNADET) | |
| Scientific Title:Acronym | LCI for SNADET | |
| Region |
|
|
| Condition | ||
| Condition | Sporadic nonampullary duodenal adenoma/carcinoma | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To reveal the efficacy of endoscopy with LCI for SNADET |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | The Visibility score of endoscopy with LCI for SNADET, and the relationship between this and the score of endoscopy with WLI, BLI, and BLI bright |
| Key secondary outcomes | The relationship between the Visibility score and patients characteristics (e.g. age, gender, and comorbidity), lesions characteristics (e.g. location, diameter, macroscopic appearance, and pathological findings) and objective assessment using graphics software |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with sporadic SNADET | |||
| Key exclusion criteria | Patients with polyposis syndrome such as FAP, or evaluated incompetent by doctors in attendance | |||
| Target sample size | 44 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Chiba University Hospital | ||||||
| Division name | Gastroenterology | ||||||
| Zip code | 260-8670 | ||||||
| Address | Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University (K1), 1-8-1, Inohana, Chuo-ku, Chiba-shi, Chiba-ken, 260-8670, Japan | ||||||
| TEL | +81-43-226-2083 | ||||||
| araim-cib@umin.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Chiba University Hospital | ||||||
| Division name | Gastroenterology | ||||||
| Zip code | 260-8670 | ||||||
| Address | 1-8-1, Inohana, Chuo-ku, Chiba-shi, Chiba-ken, 260-8670, Japan | ||||||
| TEL | +81-43-226-2083 | ||||||
| Homepage URL | |||||||
| maruoka-cib@umin.ac.jp | |||||||
| Sponsor | |
| Institute | Chiba University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Chiba University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Graduate School of Medicine, Chiba University |
| Address | 1-8-1, Inohana, Chuo-Ku, Chiba, Japan |
| Tel | 0432227171 |
| maruoka-cib@umin.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 千葉大学医学部附属病院(千葉県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691495/ |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691495/ | ||||||
| Number of participants that the trial has enrolled | 44 | ||||||
| Results | For SNADETs of 44 patients, the visibility scores of LCI (3.53+-0.59) were significantly higher than those of WLI and BLI-b (2.66+-0.79 and 3.41+-0.64, respectively). The color differences between SNADETs and the adjacent normal duodenal mucosa in LCI mode (19.09+-8.33) were significantly
higher than those in WLI and BLI-b modes (8.67+-4.81 and 12.92+-7.95, respectively). |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | In total, 44 patients and 44 lesions were evaluated. The mean age was 66.2+-9.5. Male were 32 and female were 12. The mean tumor size was 9.7+-5.9mm. | ||||||
| Participant flow | Between September 2017 and June 2019, consecutive patients diagnosed with SNADETs were enrolled in this study. | ||||||
| Adverse events | None | ||||||
| Outcome measures | Visibility score
Color difference |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Efficacy of endoscopy with LCI for SNADET will be analyzed. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033008 |